Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%

In a landmark development, global biopharmaceutical company Sanofi
will lower the price of Rifapentine, a critically important drug used
to prevent tuberculosis (TB), as part of the agreement with Unitaid,
the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official
release said on Thursday.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sanofi-inks-pact-with-unitaid-to-reduce-tb-drug-rifapentine-price-by-70/articleshow/71836241.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply